Neurocrine Biosciences Insider Sold Shares Worth $1,401,864, According to a Recent SEC Filing

Julie Cooke, Chief Human Resources Officer, on July 01, 2024, sold 10,000 shares in Neurocrine Biosciences (NBIX) for $1,401,864. Following the Form 4 filing with the SEC, Cooke has control over a tot

MT NewswiresJul 3 15:05

Neurocrine Biosciences(NBIX.US) Officer Sells US$1.4 Million in Common Stock

$Neurocrine Biosciences(NBIX.US)$ Officer Cooke Julie sold 10,000 shares of common stock on Jul 1, 2024 at an average price of $140.1864 for a total value of $1.4 million.Source: Announcement What is

Futu NewsJul 3 10:18

Neurocrine Biosciences(NBIX.US) Officer Sells US$37,565.92 in Common Stock

$Neurocrine Biosciences(NBIX.US)$ Officer Delaet Ingrid sold 272 shares of common stock on Jul 1, 2024 at an average price of $138.11 for a total value of $37,565.92.Source: Announcement What is state

Futu NewsJul 3 09:49

Citi Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Maintains Target Price $150

Citi analyst David Hoang maintains $Neurocrine Biosciences(NBIX.US)$ with a hold rating, and maintains the target price at $150.According to TipRanks data, the analyst has a success rate of 59.0% and

Futu NewsJul 2 09:31 · Ratings

Maintaining Hold on Neurocrine Biosciences Amid Efficacy Concerns and Competitive Pressures

TipRanksJul 2 09:28

Form 144 | Neurocrine Biosciences(NBIX.US) Officer Proposes to Sell 150.06K in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 1, $Neurocrine Biosciences(NBIX.US)$ Officer INGRID DELAET intends to sell 1,090 shares of its common stock on Jul 1, with a total market value of approximately $150.06K.

Futu NewsJul 2 04:41